letter to shareholders

On 12 August 2014, the Galenica Group introduced a new management structure with two units, Vifor Pharma and Galenica Santé, each headed by a CEO. Both CEOs report directly to the Executive Chairman.

Letter to Shareholders

The new management structure enables the very different Vifor Pharma and Galenica Santé business models to develop in an even more focused way, taking into account their individual growth dynamics. Galenica’s medium- to long-term vision is to develop the two units, Vifor Pharma and Galenica Santé, into two independent listed companies.

Read more about this in the Letter to Shareholders and in the Interview with Etienne Jornod, Executive Chairman of the Galenica Group.


Galenica Ltd.

Investor Relations
Untermattweg 8
CH-3027 Bern

+41 58 852 85 29
+41 58 852 85 35

Send link

Send as link